Home » FOREST LABS, SPAIN'S ALMIRALL IN DRUG DEVELOPMENT PACT
FOREST LABS, SPAIN'S ALMIRALL IN DRUG DEVELOPMENT PACT
Forest Laboratories Inc. and closely held, Barcelona-based pharmaceutical company Almirall agreed to develop, market and distribute the Spanish company's chronic obstructive pulmonary disease treatment, LAS34273, in the U.S.
Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=849628&contentType=sentryarticle&channelID=29)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May